Shams, Rayad B.
Lipner, Matthew B.
Sayed, Christopher J.
Article History
Accepted: 23 April 2024
First Online: 23 May 2024
Compliance with Ethical Standards
:
: RBS and MBL report no conflict of interests. CJS reports being an investigator for AbbVie, ChemoCentryx, Incyte, InflaRx, Novartis and UCB Pharma; consultancy fees from AbbVie, Alumis, Astrazeneca, InflaRx, Sandoz, Incyte, Logical Images, Sonoma Biotherapeutics and UCB Pharma; speaker for AbbVie and Novartis. CJS also reports being a section editor for the Dermatology and Wound Care section of Current Geriatrics Report 2024 volume.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: IRB not required.
: Not required.
: Chris J. Sayed, MD.
: We certify that the figure and table provided in this manuscript are original. They have been drafted and edited by all authors of this manuscript.